Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a minor metadata update to the page. This update does not modify the actual study details or other visible content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now lists Revision: v3.5.3, replacing v3.5.2. This indicates a small update to the page version rather than a substantive change to the study information.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision update: v3.5.0 replaced by v3.5.2. This update includes backend and UI improvements and does not modify study details or eligibility criteria.SummaryDifference0.1%

- Check58 days agoChange Detected- Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Thymus cancer to the related conditions and included a Genetic and Rare Diseases Information Center resources link.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision tag updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.